Sempra signals 20% increase in Oncor’s $47.5B capital plan while guiding to high end of $4.80-$5.30 2026 adjusted EPS range
Topics: Capital Expenditure EPS Guidance Infrastructure Investment
Read the full article at Seeking Alpha
Part of the story MetLife Reports Record Q3 2026 Adjusted EPS of $2.85 (6 articles)